semaglutide for depression Scientists Confirmed An Important Connection Between and Mental Health Semaglutide is associated with a

Drug Interaction Profile: What Clinical Evidence Shows Current pharmacokinetic data shows no direct contraindication between omeprazole and semaglutide or tirzepatide

With the growing armamentarium of options, the role of the pharmacy team will be even more integral in supporting our patients with increasing polypharmacy, such as ongoing adherence and managing potential adverse events. The US Food and Drug Administration (FDA) approved Wegovy for the same indication in March 2023 and studies have indicated patients may derive cardiovascular benefit from semaglutide regardless of weight loss

Based on extrapolated benefits from weight reduction, this combination may be considered in patients with obesity and OA who are not candidates for incretin therapies

[5] Carter, C